Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
Nature Communications
|
September 10, 2024
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
International Journal of Surgery (London, England)
|
April 7, 2023
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
Yichuan Yuan, Wei He, Zhiwen Yang, et al.
Cancer Medicine
|
May 8, 2024
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study
Liang Qiao, Wei He, Guoying Wang, et al.
BMC Cancer
|
April 18, 2015
The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
Wei He, Qingli Zeng, Yun Zheng, et al.
Journal of Cancer Research and Clinical Oncology
|
May 26, 2020
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study
Chenwei Wang, Yadi Liao, Jiliang Qiu, et al.
Annals of Translational Medicine
|
March 12, 2021
Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
Zhiyu Qiu, Lujun Shen, Yiquan Jiang, et al.
Iscience
|
July 26, 2024
Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APC<sup>min+/-</sup> mice
Yanhong Lang, Chengrui Zhong, Lingling Guo, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 2018
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis
Wenwu Liu, Yun Zheng, Wei He, et al.
International Journal of Molecular Sciences
|
July 13, 2024
KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis
Yongjin Wang, Dinglan Zuo, Zhenkun Huang, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 28, 2023
Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
Binkui Li, Jiliang Qiu, Yun Zheng, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
Nature Communications
|
September 10, 2024
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
International Journal of Surgery (London, England)
|
April 7, 2023
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
Yichuan Yuan, Wei He, Zhiwen Yang, et al.
Cancer Medicine
|
May 8, 2024
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study
Liang Qiao, Wei He, Guoying Wang, et al.
BMC Cancer
|
April 18, 2015
The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
Wei He, Qingli Zeng, Yun Zheng, et al.
Journal of Cancer Research and Clinical Oncology
|
May 26, 2020
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study
Chenwei Wang, Yadi Liao, Jiliang Qiu, et al.
Annals of Translational Medicine
|
March 12, 2021
Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
Zhiyu Qiu, Lujun Shen, Yiquan Jiang, et al.
Iscience
|
July 26, 2024
Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APC<sup>min+/-</sup> mice
Yanhong Lang, Chengrui Zhong, Lingling Guo, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 2018
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis
Wenwu Liu, Yun Zheng, Wei He, et al.
International Journal of Molecular Sciences
|
July 13, 2024
KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis
Yongjin Wang, Dinglan Zuo, Zhenkun Huang, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 28, 2023
Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
Binkui Li, Jiliang Qiu, Yun Zheng, et al.
Page
of 9